Tern Therapeutics

About:

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

Website: https://www.terntx.com/

Top Investors: Steve Oliveira, ATW Partners

Description:

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

Total Funding Amount:

$15M

Headquarters Location:

Washington, District of Columbia, United States

Founded Date:

2023-01-01

Founders:

Alex M. Bailey, Christina M. Ohnsman, Matthew Rosini

Number of Employees:

1-10

Last Funding Date:

2024-08-27

IPO Status:

Private

Industries: